Contract Services Contract Manufacturing
Manufacturing ROI Calculator - How Much Can Manufacturing Excellence Save Your Organisation?
Most manufacturers know that paper or disconnected systems on the factory floor make manufacturing operations slower and more prone to error, but the pai...
March 02, 2023 | News
AtomVie Global Radiopharma builds industry-leading CDMO facility in Ontario.
Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organi...
March 02, 2023 | News
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...
February 27, 2023 | News
GenScript ProBio and RVAC Medicines Partner for COVID-19 Vaccine Plasmid DNA Manufacturing
GenScript ProBio will provide GMP plasmid manufacturing service for RVAC Medicines' program, RVM-V001. This partnership will enable to accelerate its clini...
February 23, 2023 | News
Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
The investment has also increased the facility’s capabilities to support larger packaging campaigns through the addition of specialized secondary pac...
February 15, 2023 | News
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...
February 10, 2023 | News
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center
The additional investment for the ‘R&PD Center’ was confirmed by the board of directors committee with a total of 261 million USD SK bio...
February 08, 2023 | News
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Clinical development pipeline is essential to global business strategy Vetter Development Service offers comprehensive expertise for in-human trial mate...
February 02, 2023 | News
Strength in sustainability: Vetter wins gold in EcoVadis ranking
Vetter among the top five percent in the industry Result acknowledges strong sustainability commitment to the environment, social sector and...
January 18, 2023 | News
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...
January 11, 2023 | News
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative's ...
January 11, 2023 | News
Sarepta and Catalent Expand Strategic Manufacturing Partnership
Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, and Sarepta Therapeutics, Inc. (...
January 06, 2023 | News
WuXi STA Launches First Continuous Manufacturing Line for Oral Solids
WuXi STA’s continuous manufacturing line features continuous direct compression equipment with unit operations including dispensing, blending, lubric...
January 04, 2023 | News
Polysciences Announces New Bioprocessing Brand, Kyfora Bio
Building on Polysciences’ extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medic...
January 03, 2023 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
